Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM Academic Article uri icon


MeSH Major

  • Antineoplastic Agents
  • Laryngeal Neoplasms
  • Neoplasms, Squamous Cell


  • Radiation therapy is a mainstay of cancer treatment, yet the molecular determinants of clinical response are poorly understood. We identified exceptional responders to radiotherapy based on clinical response, and investigated the associated tumor sequencing data in order to identify additional patients with similar mutations. Among head and neck squamous cell cancer patients receiving palliative radiotherapy at our institution, we identified one patient with documented complete metabolic response. Targeted sequencing analysis of the tumor identified a somatic frame-shift mutation in ATM, a gene known to be associated with radio-sensitivity in the germline. To validate the association of somatic ATM mutation with radiotherapy response, we identified eight patients with ATM truncating mutations who received radiotherapy, all of whom demonstrated excellent responses with a median local control period of 4.62 years. Analysis of 22 DNA repair genes in The Cancer Genome Atlas (TCGA) data revealed mutations in 15.9% of 9064 tumors across 24 cancer types, with ATM mutations being the most prevalent. This is the first study to suggest that exceptional responses to radiotherapy may be determined by mutations in DNA repair genes. Sequencing of DNA repair genes merits attention in larger cohorts and may have significant implications for the personalization of radiotherapy.

publication date

  • January 2017



  • Academic Article



  • eng

PubMed Central ID

  • PMC5354661

Digital Object Identifier (DOI)

  • 10.18632/oncotarget.14400

PubMed ID

  • 28055970

Additional Document Info

start page

  • 10312

end page

  • 10323


  • 8


  • 6